Non-alcoholic fatty liver disease (NAFLD) results from triglyceride accumulation within the liver and some of them advances to non-alcoholic steatohepatitis (NASH). It is important to note that in NAFLD development, hepatic de novo lipogenesis (DNL) derives from excess carbohydrates and fats under a condition of excess energy through β-oxidation. As a main regulator for DNL, sterol regulatory element-binding protein 1 (Srebp-1) forms complex with progesterone receptor membrane component 1 (Pgrmc1). To investigate whether Pgrmc1 may have a notable effect on DNL via SREBP-1 activation, we generated Pgrmc1 knockout (KO) mice and fed a high fat diet for one month. High-fatfed Pgrmc1 KO mice showed a substantial increase in levels of hepatic TG accumulation, and they were predisposed to NAFLD when compared to WT mice. Loss of Pgrmc1 increased mature SREBP-1 protein level, suggesting that induction of hepatic steatosis in Pgrmc1 KO mice might be triggered by de novo lipogenesis. Moreover, Pgrmc1 KO mice were also more vulnerable to early stage of NASH, showing high levels of alanine aminotransferase, obesity-linked pro-inflammatory cytokines, and fibrosis markers. This is interesting because Pgrmc1 involves with the first step in regulating the hepatic de novo lipogenesis under an excess energy condition.
detected in various tissues such as the liver, lung, kidney, and brain [19] [20] [21] . Furthermore, PGRMC1 is a member of the PGRMC1/INSIG-1 complex, which is located in the ER of human and rodent liver. In addition to its role as a regulator of cancer cell survival, Pgrmc1 also affects cholesterol synthesis and steroidogenesis 18, [22] [23] [24] . Moreover, a recent study revealed that PGRMC1 binds to INSIG-1 and subsequently regulates SCAP and SREBP-1 that are closely related to triglyceride synthesis 25 .
In the present study, we focused on the role of Pgrmc1 as a regulator of Srebp-1 in the hepatic DNL pathway. In our preliminary data, we have evidence that Pgrmc1 and Srebp-1 are associated by inverse-proportional expression. To investigate whether Pgrmc1 actually regulates lipogenesis, we generated Pgrmc1 knockout (KO) mice, fed them with a high fat diet, and assessed whether the loss of Pgrmc1 predisposes mice to NAFLD and results in the buildup of fatty acids via the DNL pathway.
Result
Generation of Pgrmc1 knockout mice. Considering that Pgrmc1 is highly expressed in liver, it can be speculated that Pgrmc1 is related to general liver function. To investigate role of Pgrmc1, we generated the knockout mice using transcription activator-like effector nuclease (TALEN). An illustration of genome targeting and editing strategy in exon 1 was as shown in Fig. 1A . Whether Pgrmc1 allele was ablated was investigated using T7 endonuclease (T7E1) assay and genomic DNA sequencing was performed to elucidate 8 base pair (bp) deletion with a frameshift in founder #1 (Fig. 1B) . By crossing with wild-type, the progeny of founder #1 showed wildtype and heterozygote band exclusively, indicating that germline transmission was successful (Fig. 1C ). Even though TALEN has successfully deleted on-target sites at exon 1, potential off-target sites of Pgrmc1-TALEN were analyzed. Sequences of expected off-target sites are as listed in Table 1 . With 3-5 base pairs of mismatch, chromosomes 1, 5, 6, 12, and 17 were examined by T7E1 assay and genotyping were conducted. Compared with wild-type band, none of the chromosomes were off-targeted ( Fig. S1 ). The absence of Pgrmc1 was confirmed by PCR genotyping, western blot analysis, and immunohistochemistry in liver ( Fig. 2A-C ). Wild-type allele was detected as 128 bp and mutant allele was 120 bp in size ( Fig. 2A ). PGRMC1 protein was detected in protein extracts from the tissues of wild-type, while this band was absent from those of Pgrmc1 KO mice, which confirms the ablation of the PGRMC1 protein ( Fig. 2B ). Immunohistochemistry of the liver and uterus also demonstrated that PGRMC1 protein was completely depleted in Pgrmc1 KO mice ( Fig. 2C ). To sum it up, expression tests confirmed that functional PGRMC1 was completely depleted in knockout mice.
Hepatic TG accumulation significantly increases in Pgrmc1 KO mice. Control WT and Pgrmc1 KO groups were fed a normal diet and experimental WT and Pgrmc1 KO groups were fed a high fat diet for 1 month. After necropsy, high-fat-fed Pgrmc1 KO mice showed increased lipid accumulation within the liver when compared to high-fat-fed WT mice. Lipid droplets observed in H&E stained liver sections were remarkably larger in high-fat-fed Pgrmc1 KO mice when compared to that of WT mice (Fig. 3A ). In addition, on Oil-Red-O staining, lipid droplets were stained with red orange color and its quantification showed an increase (P < 0.05, 1.43 fold) in high-fat-fed Pgrmc1 KO mice ( Fig. 3B,C) . Similarly, after extracting lipids from the liver, triglyceride levels were measured with a commercial kit mentioned above and it showed significantly increased (P < 0.05, 1.12 fold) in the liver of high-fat-fed Pgrmc1 KO mice when compared to high-fat-fed WT mice ( Fig. 3D ). These results suggest that numerous lipid droplets in Oil-Red-O staining were triglycerides, which accumulated within the liver of high-fat-fed Pgrmc1 KO mice. On the other hand, there was a slight decrease (P = 0.14, 68.5%) in serum TG levels in high-fat-fed Pgrmc1 KO mice when compared to high-fat-fed WT mice and Pgrmc1 KO mice fed a normal diet also showed a decrease (P < 0.05, 56.8%) in serum TG levels when compared to WT mice fed a normal diet ( Fig. 3E ). Meanwhile, serum free fatty acid (FFA) levels in high-fat fed Pgrmc1 KO mice significantly increased (P < 0.05, 1.16 fold) than those of high-fat-fed WT mice ( Fig. 3F) . Similarly, Pgrmc1 KO mice fed a normal diet showed significantly increased (P < 0.05, 1.18 fold) serum FFA levels when compared to WT mice fed a normal diet ( Fig. 3F ). TG accumulation in Pgrmc1 KO liver links to increase of Srebp-1 level. First, we assessed transcriptional regulator genes involved in fatty acid synthesis, such as Pparγ, Lxr, and Srebp-1. As a result, Srebp-1 mRNA level significantly increased (P < 0.05, 4.02 fold) in high-fat-fed Pgrmc1 KO mice when compared to high-fat-fed WT mice ( Fig. 4A ). Although Pparγ and Lxr mRNA levels increased in high fat diet, the differences between WT mice and Pgrmc1 KO mice were not observed ( Fig. S2A ). Meanwhile, protein levels of SREBP-1 precursor were increased in WT and Pgrmc1 KO mice fed a high fat diet (P < 0.05, 3.1 fold and 2.8 fold) than normal diet, but the differences between WT mice and Pgrmc1 KO mice were not observed ( Fig. 4B ). Rather, protein levels of mature SREBP-1 were significantly increased in Pgrmc1 KO mice fed a normal diet (2.01 fold) and high fat diet (1.53 fold), when compared to those of WT mice (P < 0.05, Fig. 4B ). These results suggest that level of active SREBP-1 protein is induced by loss of PGRMC1. Accordingly, among the genes directly controlled by SREBP-1, Acc mRNA levels was increased (P < 0.05, 1.7 fold) in high-fat-fed Pgrmc1 KO mice when compared to high-fat fed WT mice ( Fig. 4C ). In addition, fatty acid esterification enzymes, Agpat1 (1.94 fold) and Mogat1 (2.99 fold), were significantly (P < 0.05) increased in mRNA levels of high-fat-fed Pgrmc1 KO mice than high-fat-fed WT mice ( Fig. S2B ). These results suggest that TG accumulation was promoted under condition of increase of Srebp-1 level, as a phenotype of Pgrmc1 KO mice. Interestingly, both mRNA (2.09 folds, Fig. S3 ) and protein (1.43 fold, Fig. 4B ) level of Pgrmc1 were increased (P < 0.05) in high-fat-fed WT mice than WT mice fed a normal diet, suggesting that Pgrmc1 can also be used as potential biomarker in steatosis. Meanwhile, Insig-1, which forms complex with Pgrmc1, also significantly showed increase (P < 0.05, 3.74 and 2.11 fold) in mRNA level in Pgrmc1 KO mice, when compared to WT mice in normal diet or high fat diet ( Fig. S3 ). Likewise, Scap, which forms with Pgrmc1 and Insig-1, increased in mRNA level (1.29 fold, P = 0.33) in Pgrmc1 KO mice, but showed no significance ( Fig. S3 ).
Loss of Pgrmc1 promotes steatosis-induced NASH.
As a hepatic injury marker, ALT levels were measured in serum. As a result, normal diet (1.29 fold) and high-fat-fed (1.26 fold) Pgrmc1 KO mice showed significantly (P < 0.05) higher levels of ALT than those of WT mice fed with a normal diet and high fat diet ( Fig. 5A ). Moreover, to assess the level of genes followed by hepatic inflammation, we analyzed Tnf (1.2 fold), Il-6 (1.32 fold), and Il-1β (1.72 fold) mRNA levels and observed significant (P < 0.05) increases in high-fat-fed Pgrmc1 KO mice than those of high-fat-fed WT mice ( Fig. 5B-D) . In addition, we monitored macrophage infiltration in liver using a F4/80 antibody, macrophage marker, F4/80. Although liver has resident macrophage like Kupffer cells, the increased macrophage (F4/80-positive) infiltration in Pgrmc1 KO mice suggests possibility for inflammation of NASH (Fig. S4 ). This result also suggests that the macrophage infiltrate the liver in response to NAFLD challenge. Likewise, the mRNA level of Scd1, which is protective to lipotoxicity, showed significant decrease (P < 0.05) in Pgrmc1 KO mice fed a normal diet (33.8%) and high fat diet (32.5%) when compared to those of WT mice (Fig. 5E ).
To further evaluate NASH under condition of high-fat diets, we monitored the hepatic fibrosis using Masson's trichrome staining. As expected, high-fat-fed Pgrmc1 KO mice showed significantly higher ratio of blue-stained fibroblasts compared to those within WT mice fed with a normal diet and high fat diet, and the fibroblasts was mainly confined around the central vein of lobules ( Fig. 6A ). As another fibrosis marker, the level of Tgf-β mRNA also showed significant (P < 0.05) increase in both of normal diet-fed (1.46 fold) and high-fat-fed (1.58 fold) Pgrmc1 KO mice than those of WT mice (Fig. 6B) . These results suggest that Pgrmc1 KO mice are genetically more prone to NAFLD-induced liver inflammation or NASH. Liver-specific regulation of PGRMC1 controls level of SREBP-1 and steatosis. For inducing lipogenesis, palmitic acid (330 μM) and oleic acid (660 μM) were treated for 48 hours and AG-205 was co-incubated in Hep3B cells. As a result, Oil-Red-O stained areas were significantly decreased (P < 0.05, 74.1%) in fatty acid + AG-205-treated group when compared to the fatty acid treated group, suggesting that lipid storage has been significantly reduced ( Fig. 7A,B ). Moreover, after treating fatty acids for 4 hours with pre-incubation of AG-205 for 12 hours, PGRMC1 mRNA level increased (P < 0.05, 1.23 fold) in fatty acid + AG-205 group when compared to fatty acid group (Fig. 7C ). On the one hand, SREBP-1 mRNA level was inversely proportional to PGRMC1 mRNA level, showing decreased level (P < 0.05, 75.8%) in the fatty acid + AG-205 group when compared to AG-205 group (Fig. 7D) . These results show that up-regulation of PGRMC1 down-regulates lipid accumulation in hepatocyte with decreased level of SREBP-1.
To investigate whether the lipogenic effect in the loss of Pgrmc1 is liver-specific, we therefore introduced primary hepatocyte culture system and observed significantly increased (P < 0.05, 1.3 fold) level of mature SREBP-1 protein in Pgrmc1 KO hepatocytes when compared to WT hepatocytes (Fig. 7E) . Likewise, level of mature SREBP-1 protein also significantly increased (P < 0.05, 1.31 fold) in fatty acid treated Pgrmc1 KO hepatocytes when compared to that of WT hepatocytes (Fig. 7F) . The phenotypic characteristic of Pgrmc1 was also confirmed by siRNA transfection with significantly increased (P < 0.05, 1.36 fold) level of mature SREBP-1 protein in PGRMC1 knockdown Hep3B cell when compared to control cell (P < 0.05, 65%, Fig. S7 ).
Discussion
The fatty liver is predisposed to injuries involving oxidant stress, which subsequently leads to inflammation 26 . NASH, the typical feature of NAFLD, occurs during accumulation of fatty acids following hepatic de novo lipogenesis or plasma lipid transport from extrahepatic tissues 27, 28 . In addition, numerous studies reported that steatohepatitis increased the risk of HCC 28, 29 . Interestingly, the present study shows that Pgrmc1 KO mice are vulnerable to NAFLD triggered by a high-fat diet when compared to WT mice. Moreover, Pgrmc1 KO mice were predisposed to liver inflammation and fibrosis; therefore, loss of Pgrmc1 can increase the risk of hepatic diseases such as NAFLD and NASH under high-fat diets typical of western societies.
After mice were fed a high-fat diet, Pgrmc1 KO mice showed significant increases in hepatic TG accumulation. Pgrmc1 KO mice also showed significant increases in plasma FFA, while plasma TG revealed a corresponding reduction in levels. In a recent study, patients with NAFLD had accumulation of TG within the liver mainly from hepatic de novo lipogenesis rather than from plasma fatty acids 30 . Thus, we focused on hepatic lipogenesis to investigate the mechanism of increased hepatic steatosis in the loss of Pgrmc1.
To assess the transcription regulating gene involved in fatty acid synthesis of lipogenesis, we observed the increase of Srebp-1 level following the loss of Pgrmc1. When SREBP-1 is the primary regulator of fatty acid synthesis and TG storage within the liver 31 , it was found to be inactive in its precursor form under non-high fat conditions. After being cleaved from the SCAP/SREBP-1 complex through signaling, SREBP-1 becomes mature and plays a role as a transcriptional factor for triggering hepatic de novo lipogenesis 32 . The signal for cleavage of the SCAP/SREBP-1 complex is transmitted from the PGRMC1/INSIG-1 complex, implying that PGRMC1-is closely involved with SREBP-1 function. More recently, it was reported that SCAP/SREBP-1 expression increases under a condition of low PGRMC1/INSIG-1 expression 25 . Likewise, the present study shows significantly increased levels of Srebp-1 mRNA and mature SREBP-1 protein in the absence of Pgrmc1. Since induction of SREBP-1 has been linked to the accumulation of TG within the liver through de novo lipogenesis 33 , our data support the claim that hepatic TG accumulates within the Pgrmc1 KO liver following an increase of Srebp-1 levels.
In addition, our results provide evidence that Pgrmc1 has a novel function as an inhibitory factor of hepatic de novo lipogenesis. As a Srebp-1-dependent protein, ACC plays a crucial role in lipogenesis and fatty acid synthesis 34, 35 as its protein product is responsible for the carboxylation of acetyl-CoA to malonyl-CoA. Furthermore, reduction of its inactive form was also used as an indicator of lipogenesis 36 . In this study, we observed an increased level of Acc in the absence of Pgrmc1, with increased SREBP-1 level. Moreover, we observed increased transcript level of fatty acid esterification enzymes, Agpat and Mogat, which may promote the growth of lipid droplets and TG accumulation in the absence of Pgrmc1 37,38 . These data, therefore, suggest that Pgrmc1 KO mice are predisposed to lipogenesis in the liver. On the other hand, an increased level of fatty acid metabolism genes was observed after the loss of Pgrmc1 (Figs S5 and S6 ), suggesting that TG accumulation in Pgrmc1 KO liver was not induced by impaired fatty acid degradation.
Next, we observed an unexpected reduction in transcripts related to lipogenesis (Scd1 mRNA) in the absence of Pgrmc1 in both groups fed a normal diet and a high fat diet. Pgrmc1 KO mice have a phenotype showing low levels of Scd1 transcript, Scd1 being the primary regulator in fatty acid synthesis, converting saturated fatty acids to monounsaturated fatty acids and preventing lipotoxicity [37] [38] [39] . As the Scd1 gene plays a key role in preventing steatohepatitis, Pgrmc1 deficiency could lead to a NASH-susceptible state, like that of Scd1 KO mice 38 . Therefore, our data suggest that Pgrmc1 KO mice are genetically more vulnerable to lipotoxicity acquired by hepatic steatosis. Meanwhile, plasma alanine aminotransferase (ALT) is a well-known marker for inflammation as it is located inside the liver cell and increases after hepatocyte damage. Lipotoxicity due to low Scd1 levels after the loss of Pgrmc1 should be linked to plasma ALT levels, and Pgrmc1 KO mice showed enhanced levels of ALT over WT mice both in a normal diet and a high-fat diet. Though NASH is not always concomitant with ALT 40 , we supported our claim with the increased level of obesity-linked pro-inflammatory cytokines, IL-6 and TNF 41 . These cytokines are well known mediators for inflammation or HCC induced by hepatic steatosis, because IL-6 is involved in low-grade chronic inflammation and poor prognosis of NAFLD 42, 43 . In addition, we observed an increase of macrophage infiltration in the absence of Pgrmc1, suggesting a high possibility for inflammation triggered by NASH. Likewise, considerable increases of fibroblasts and Tgfb transcript level also suggest susceptibility to fibrosis induced by steatosis in the loss of Pgrmc1 44, 45 . Therefore, based on our results, Pgrmc1 KO mice might have high risk factors for NASH including liver inflammation and fibrosis, and HCC triggered by a high-fat diet.
To gain insight into the correlation between Pgrmc1 and hepatic lipogenesis, we introduced AG-205 into Hep3B cells in a medium supplemented with fatty acids. Similar to the in vivo data, when PGRMC1 mRNA level increased significantly after treatment with AG-205, fat storage significantly decreased in the PGRMC1-induced condition. In addition, PGRMC1 directly regulated the mRNA level of SREBP-1, suggesting that lipogenesis could also be controlled by following PGRMC1 promotion. Meanwhile, we further confirmed that lipogenic control of Pgrmc1 is liver-specific by introducing a primary hepatocyte culture, observing increased levels of mature SREBP-1 in Pgrmc1 KO hepatocytes. Likewise, we also decreased the level of PGRMC1 and observed an increased level of mature SREBP-1 in siRNA transfection.
In summary, our study suggests that the loss of Pgrmc1 within the liver not only increases cellular lipid levels, but also enhances the risk for steatohepatitis. These findings are particularly interesting for cancer cell metabolism in light of reports that regard Pgrmc1 as a clinical parameter for hepatocellular carcinoma 46 and find that Pgrmc1 is strongly expressed in different kinds of cancer 47, 48 . We also suggest that the loss of Pgrmc1 might enhance sensitivity for lipotoxicity in animals and possibly humans even under a low-lipid diet.
Materials and Methods
Antibodies. Rabbit polyclonal antibody for Beta-actin (sc-130656) was purchased from Santa Cruz biotechnology (Santacruz, CA, USA). Rabbit monoclonal antibody specific for Pgrmc1 (CST, #13856) was purchased from CST. Mouse monoclonal antibody specific for Srebp1 (sc-13551) was purchased from Santacruz.
Animals. Pgrmc1 KO mice were generated by TALEN method. Pgrmc1 specific TALEN plasmids were obtained from ToolGen, Inc. (South Korea). General methods for TALEN mediated KO mice production were previously described 49 . Briefly, Single dose of Pgrmc1 TALEN mRNA (50 ng/ul) was injected into the cytoplasm of C57BL/6 N mouse eggs with well recognized pronuclei and transferred into the oviducts of pseudo-pregnant foster mothers. To evaluate non-specific effects of TALEN, potential off-target sites were predicted as previously described 50 (Table 1) , and T7E1 assays were performed using genomic DNA samples from F0 mutant mice. For routine PCR genotyping of F1 progeny from selected F0 founder mice, the following primer pair was designed to amplify a 128 bp PCR product from wild-type mice and TALEN-induced mutant alleles: 5′-GGCTGCTGCACGAGATTTTC-3′ and 5′-GGTGGTTCGTCGTCGTCGTTG-3′ ( Fig. 1 ).
C57BL/6N WT and Pgrmc1 KO female mice were housed in the pathogen-free facility at Chungnam National University and fed with standard chow and high fat diet with water provided ad libitum. All mouse experiments were approved and performed in accordance with the Chungnam National University Animal Care Committee (CNU-00606). Sacrifice was performed by CO 2 asphyxiation. Number of mice used for experiment was 3 for each normal diet groups and 4 for each high fat diet groups.
Plasma TG, FFA and ALT level. Liver TG level. Lipid extraction from liver was done with Folch method. 0.2 g of liver tissue was homogenized with beads and 0.9% NaCl solution. After mixing with chloroform and methanol (1:2), samples were let stand for 30 minutes on room temperature. Additional mix with chloroform and distilled water, lower phase was separated after centrifuged on 3,000 rpm, 20 mins. Steps after homogenization were repeated for 3 times. Samples were filtrated with filter paper and the flow-through was heated in water bath. By this step, chloroform phase was evaporated. After complete dry in dry oven, it was dissolved in chloroform and 2-propanol. Samples were stored in room temperature. TG level was analyzed with TG measurement solution (AM157S-K, Asan-Set) in 550 nm spectrophotometer RNA Isolation, reverse transcription, and qRT-PCR. Total RNA extracts from mouse liver or Hep3B cells were prepared using the TRIzol ® Reagent (Thermo Fisher Scientific, MA, USA). Reverse transcription was performed with 1.5 µg of total RNA and Reverse transcriptase kit (SG-cDNAS100, Smartgene, United Kingdom) following manufacturer's protocol. Quantitative PCR (real-time PCR) was carried out using specific primers ( Table 2) For Oil-Red-O, frozen tissue were cut by 7 μM after embedded with OCT compound and attached to silane coated slide. After drying 10 mins in RT, slides were fixed with formalin for 20 mins and washed with running tap water for 10 mins. Slides were proceeded to rinse step with 60% isopropanol and stained with Oil Red O working solution (3 g/l) for 15 mins. After washing with 60% isopropanol, slides were stained with hematoxylin for 30 secs and rinsed with distilled water. Region of interest was observed by light microscope after mounted in aqueous mountant.
For immunofluorescence, frozen tissue were cut by 7 μM after embedded with OCT compound and attached to silane coated slide. After drying 10 mins in RT, slides were fixed with cold methanol for 20 mins in −20 °C. Slides were proceeded to permeabilization step with 0.5% triton x-100 and blocked by 3% BSA in TBS-T. Primary antibody (F4/80, ab6640, abcam) was incubated for O/N in 4 °C. After three times of wash with TBS-T, secondary antibody (A21202, Life Technologies) was incubated for 3 hrs in RT. Region of interest was observed in dark area with microscope (DMi8, Leica).
Cell culture. Hep3B cells were cultured in DMEM-High glucose medium (LM 001-05). DMSO and AG-205(10 mg/ml, A1478, sigma) were treated for indicated hours before high fat treatment. Fatty acids (Palmitic acid 330 μM, Oleic acid 660 μM) were treated for each indicated hours.
SiRNA transfection was performed with lipofectamine 2000 (11668-027, Thermofisher) according to the manufacturer's protocol. Negative control siRNA and PGRMC1 siRNA #1 and #2 were purchased from Bioneer (Daejoen, Korea). The sense sequences of PGRMC1 siRNA #1 and #2 were 5′-CAGUACAGUCGCUAGUCAA-3′ and 5′-CAGUUCACUUUCAAGUAUCA-U-3′.
Primary hepatocytes were isolated from mice by collagenase digestion and Percoll Gradient method. Briefly, mice were anesthetized, and the peritoneal cavity was opened. Livers were perfused with Ca 2+ and Mg 2+ Scientific REPORTS | (2018) 8:15711 | DOI:10.1038/s41598-018-34148-6 free-HBSS containing EDTA (1 mM) (LB203-56, Welgene) and then digested with a collagenase solution containing liberase (Research grade, Sigma). Digested livers were removed and rinsed twice with HBSS and then gently teased with forceps until they were in solution. The cell suspensions were filtered through a sterile 40-μm nylon cell strainer (SPL) to remove undigested tissue and connective tissue. The cells were centrifuged for 5 min at 1000 rpm and resuspended with medium. The pellet suspensions were centrifuged using 35% Percoll for 15 min at 2000 rpm with the brake option off. After centrifugation, the healthy hepatocytes were pelleted as damaged hepatocytes, or nonparenchymal cells could not penetrate into 35% Percoll solution. The pellets were washed twice with DMEM supplemented with 5%FBS, and then seeded into six well tissue culture plates. After 24 hrs, nonadherent cells were removed by aspiration.
Statistical analysis. Data are reported as mean ± SD. Differences between means were obtained by Student's t-test was performed using Graph Pad Software (GraphPad Inc., San Diego, CA).
